Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 17198275)

Published in Transplantation on December 27, 2006

Authors

Diana M Girnita1, Steven A Webber, Robert Ferrell, Gilbert J Burckart, Maria M Brooks, Kevin K McDade, Richard Chinnock, Charles Canter, Linda Addonizio, Daniel Bernstein, James K Kirklin, Alin L Girnita, Adriana Zeevi

Author Affiliations

1: Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.

Articles citing this

Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study. Pediatr Transplant (2011) 1.45

Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38

Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens (2008) 1.26

IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians. Hum Genet (2010) 0.99

Renal function and genetic polymorphisms in pediatric heart transplant recipients. J Heart Lung Transplant (2012) 0.96

Racial and ethnic differences in mortality in children awaiting heart transplant in the United States. Am J Transplant (2009) 0.87

Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia. PLoS One (2014) 0.83

Effect of cytokine and pharmacogenomic genetic polymorphisms in transplantation. Curr Opin Immunol (2008) 0.81

Improved survival in pediatric heart transplant recipients: have white, black and Hispanic children benefited equally? Am J Transplant (2011) 0.81

Improved survival in heart transplant recipients in the United States: racial differences in era effect. Circ Heart Fail (2011) 0.81

Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia. Haemophilia (2010) 0.81

Genotypic variation and phenotypic characterization of granzyme B gene polymorphisms. Transplantation (2009) 0.80

Inosine 5'-monophosphate dehydrogenase 1 haplotypes and association with mycophenolate mofetil gastrointestinal intolerance in pediatric heart transplant patients. Pediatr Transplant (2010) 0.79

Multi-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2. J Pediatr Pharmacol Ther (2014) 0.77

Pharmacogenomics: personalizing pediatric heart transplantation. Circulation (2015) 0.75

Single nucleotide polymorphisms for genes encoding cytokines in the context of cardiac surgery. Part I: Heart transplantation. Kardiochir Torakochirurgia Pol (2015) 0.75

Personalized treatment in heart transplantation. Curr Opin Organ Transplant (2017) 0.75

Articles by these authors

Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet (2009) 6.82

Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med (2013) 6.31

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87

Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA (2006) 4.51

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90

Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med (2004) 3.32

A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med (2006) 3.16

Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet (2007) 2.91

Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am J Prev Med (2009) 2.88

Prevention of pediatric graft coronary artery disease: atorvastatin. Pediatr Transplant (2008) 2.79

Temporal response of the human virome to immunosuppression and antiviral therapy. Cell (2013) 2.72

Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention. Diabetes Care (2006) 2.59

The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant (2010) 2.59

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55

INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant (2009) 2.49

The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med (2014) 2.38

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacotherapy (2008) 2.34

Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion (2006) 2.26

The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res (2005) 2.24

Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation (2006) 2.24

New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol (2008) 2.23

Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation (2002) 2.14

Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation (2006) 2.01

National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93

The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr (2009) 1.82

The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr (2012) 1.82

Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation (2011) 1.81

In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium. Arterioscler Thromb Vasc Biol (2011) 1.80

Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report--2005. J Heart Lung Transplant (2005) 1.75

Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation (2004) 1.73

The effect of bioengineered acellular collagen patch on cardiac remodeling and ventricular function post myocardial infarction. Biomaterials (2013) 1.68

FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. J Clin Invest (2013) 1.65

Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62

International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant (2004) 1.59

Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant (2003) 1.58

Ventricular assist device support in children and adolescents as a bridge to heart transplantation. Ann Thorac Surg (2006) 1.57

Loss of adenomatous poliposis coli-α3 integrin interaction promotes endothelial apoptosis in mice and humans. Circ Res (2012) 1.56

Pulmonary transplantation for advanced bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg (2003) 1.54

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. Am J Epidemiol (2004) 1.52

Extrapolation of adult data and other data in pediatric drug-development programs. Pediatrics (2011) 1.50

A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet (2002) 1.49

Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant (2006) 1.48

Use of an intraperitoneal ventricular assist device with a polytetrafluoroethylene barrier decreases infections. J Heart Lung Transplant (2008) 1.47

Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients. Pediatr Transplant (2008) 1.46

HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant (2005) 1.46

Microarray analysis of gene expression after transverse aortic constriction in mice. Physiol Genomics (2004) 1.44

Total anomalous pulmonary venous connection: morphology and outcome from an international population-based study. Circulation (2010) 1.43

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43

Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data. J Heart Lung Transplant (2010) 1.43

Live three-dimensional transthoracic echocardiographic assessment of left atrial tumors. Echocardiography (2005) 1.43

Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2007) 1.43

Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry. Biol Psychiatry (2012) 1.43

Multiple listing for pediatric heart transplantation in the U.S.A.: analysis of OPTN registry data from 1995 through 2009. Pediatr Transplant (2013) 1.42

Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): the INOP Test Study Group. Circulation (2002) 1.40

Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: second annual report--2004. J Heart Lung Transplant (2004) 1.40

Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40

Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle heart failure model. ASAIO J (2012) 1.39

Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension. Circ Res (2005) 1.37

Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect Immun (2006) 1.36

The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin (2010) 1.34

Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol (2009) 1.34

Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant (2010) 1.31

Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30

Definitive diagnosis of cor triatriatum with common atrium by three-dimensional transesophageal echocardiography in an adult. Echocardiography (2004) 1.30

Survival in allosensitized children after listing for cardiac transplantation. J Heart Lung Transplant (2007) 1.30

Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med (2003) 1.28

Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant (2003) 1.28

HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant (2004) 1.27

Measurement of Epstein-Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR. J Clin Microbiol (2003) 1.27

The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol (2009) 1.24

The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia. FASEB J (2009) 1.22

Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg (2009) 1.21

Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry (2009) 1.21

Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant (2003) 1.21

The effect of obesity on quality of life in patients with diabetes and coronary artery disease. Am Heart J (2010) 1.21

Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses. J Mol Cell Cardiol (2004) 1.21

Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. J Nucl Cardiol (2012) 1.21

INTERMACS: interval analysis of registry data. J Am Coll Surg (2009) 1.20

Pulmonary atresia with intact ventricular septum: range of morphology in a population-based study. J Am Coll Cardiol (2002) 1.19

Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant (2008) 1.19

3-year follow-up of clinical and behavioral improvements following a multifaceted diabetes care intervention: results of a randomized controlled trial. Diabetes Educ (2010) 1.19

Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause (2011) 1.19

Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet (2006) 1.17

Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol (2003) 1.17

Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Hum Immunol (2008) 1.16

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant (2016) 1.16